CNBX Pharmaceuticals replaces auditor Elkana Amitai CPA with Vilki & Co
CNBX•CNBX Pharmaceuticals dismissed Elkana Amitai CPA effective Sept. 28, 2026, and engaged Vilki & Co as its independent auditor for the year ended Aug. 31, 2026.
1. Auditor change
CNBX Pharmaceuticals dismissed Elkana Amitai CPA effective Sept. 28, 2026, and engaged Vilki & Co as its new independent auditor for the year ended Aug. 31, 2026. The audit reports for fiscal 2024 and 2025 included a going-concern emphasis paragraph; the company reported no disputes with its former auditor over accounting, disclosure or audit scope.
